Measurements and Characterization of Doppler Signals From the Right Chest in Pediatric and Adult Patients
Status: | Recruiting |
---|---|
Conditions: | High Blood Pressure (Hypertension), High Blood Pressure (Hypertension) |
Therapuetic Areas: | Cardiology / Vascular Diseases |
Healthy: | No |
Age Range: | Any |
Updated: | 7/27/2018 |
Start Date: | July 2013 |
End Date: | April 2019 |
Contact: | Jeffrey Feinstein, MD |
Email: | jeff.feinstein@stanford.edu |
Phone: | (650) 723-7913 |
Evaluation of Lung Doppler Signals in Pediatric and Adult Patients
Recently it has been shown that clear reproducible Doppler signals can be recorded from the
lung parenchyma by means of a pulsed Doppler ultrasound system incorporating a special signal
processing package parametric Doppler, TPD, EchoSense Ltd., Haifa, Israel). These lung
Doppler signals (LDS) are in full synchrony with the cardiac cycle and can be obtained from
the lungs, including areas remote from the heart and main pulmonary vessels. The LDS waves
typically have peak velocities of up to 30 cm/s and are of relatively high power, making it
possible to detect them despite the aforementioned attenuation by the air in the lungs. The
LDS are thought to represent the radial wall movement of small pulmonary blood vessels,
caused by pressure pulse waves of cardiac origin which propagate throughout the lung
vasculature. The LDS may contain information of significant diagnostic and physiological
value regarding the pulmonary parenchyma and vasculature, as well as the cardio-vascular
system in general.
Pulmonary arterial hypertension (PAH) is a condition characterized by reshaping of the small
pulmonary arteries with increase in pulmonary vascular resistance, leading gradually to
right-sided cardiac failure. A trans-thoracic echocardiograph (TTE) is a test classically
undertaken in order to screen for pulmonary hypertension. However, the systolic pulmonary
artery pressure (SPAP) values thereby obtained are often imprecise and depend upon the
expertise of the individual carrying out the test. Therefore, the pulmonary arterial pressure
and cardiac output values have to be ascertained with a right-sided cardiac catheterization,
which is considered the gold-standard, but is invasive.
In a pilot study of adult PAH patients (unpublished), lung Doppler signals have been shown to
have the potential to diagnose pulmonary hypertension in two different ways: First, by
measuring the degree of attenuation of the LDS during acute pressure rise in the chest cavity
(i.e. during Valsalva maneuver). Second, by detecting differences between the LDS in patients
with PAH and control subjects.
One of the objectives of the present study is to evaluate the lung Doppler signals in
pediatric patients of various age groups, with and without pulmonary vascular disease. The
second objective of the study is to verify previous findings of abnormal lung Doppler signals
in adult patients with pulmonary hypertension.
lung parenchyma by means of a pulsed Doppler ultrasound system incorporating a special signal
processing package parametric Doppler, TPD, EchoSense Ltd., Haifa, Israel). These lung
Doppler signals (LDS) are in full synchrony with the cardiac cycle and can be obtained from
the lungs, including areas remote from the heart and main pulmonary vessels. The LDS waves
typically have peak velocities of up to 30 cm/s and are of relatively high power, making it
possible to detect them despite the aforementioned attenuation by the air in the lungs. The
LDS are thought to represent the radial wall movement of small pulmonary blood vessels,
caused by pressure pulse waves of cardiac origin which propagate throughout the lung
vasculature. The LDS may contain information of significant diagnostic and physiological
value regarding the pulmonary parenchyma and vasculature, as well as the cardio-vascular
system in general.
Pulmonary arterial hypertension (PAH) is a condition characterized by reshaping of the small
pulmonary arteries with increase in pulmonary vascular resistance, leading gradually to
right-sided cardiac failure. A trans-thoracic echocardiograph (TTE) is a test classically
undertaken in order to screen for pulmonary hypertension. However, the systolic pulmonary
artery pressure (SPAP) values thereby obtained are often imprecise and depend upon the
expertise of the individual carrying out the test. Therefore, the pulmonary arterial pressure
and cardiac output values have to be ascertained with a right-sided cardiac catheterization,
which is considered the gold-standard, but is invasive.
In a pilot study of adult PAH patients (unpublished), lung Doppler signals have been shown to
have the potential to diagnose pulmonary hypertension in two different ways: First, by
measuring the degree of attenuation of the LDS during acute pressure rise in the chest cavity
(i.e. during Valsalva maneuver). Second, by detecting differences between the LDS in patients
with PAH and control subjects.
One of the objectives of the present study is to evaluate the lung Doppler signals in
pediatric patients of various age groups, with and without pulmonary vascular disease. The
second objective of the study is to verify previous findings of abnormal lung Doppler signals
in adult patients with pulmonary hypertension.
Inclusion Criteria:
- Adults undergoing RHC:
- Males or females aged over 18 years
- With suspicion or diagnosis of pulmonary hypertension.
- Scheduled to undergo right heart catheterization
- Able and willing to give informed consent
Pediatric patients undergoing RHC:
- Males or females aged 0-18 years
- Scheduled to undergo right hear catheterization
- Parents willing to give informed consent
Pediatric patients without significant cardio-pulmonary diseases:
- Males or females aged 0-18 years Not known to have a significant cardiac or pulmonary
disease
- Legal guardians willing to give informed consent
Exclusion Criteria:
- -Hemodynamically unstable patients.
- For adult and pediatric patients undergoing right heart catheterization:
a. Any contra-indication to perform the procedure
- For adults only:
1. Patients incapable of performing a Valsalva maneuver
2. Patients with recent (within the past 3 months) myocardial infarction, high
degree AV block, severe aortic stenosis or open angle glaucoma
We found this trial at
2
sites
725 Welch Road
Palo Alto, California 94304
Palo Alto, California 94304
Phone: 650-723-7913
Click here to add this to my saved trials
Click here to add this to my saved trials